Mode of Interaction between β2GPI and Lipoprotein Receptors Suggests Mutually Exclusive Binding of β2GPI to the Receptors and Anionic Phospholipids

Structure

Volumn 18, Issue 3, 2010, Pages 366-376

  Lee, Chang Jin ^a   De Biasio, Alfredo ^a   Beglova, Natalia ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

PROTEINS; SIGNALING

Indexed keywords

ANION; APOLIPOPROTEIN E RECEPTOR 2; BETA2 GLYCOPROTEIN 1; CALCIUM; LIPOPROTEIN RECEPTOR; PHOSPHOLIPID; PROTEIN ANTIBODY; UNCLASSIFIED DRUG; LIGAND; MULTIPROTEIN COMPLEX;

ANTIGEN BINDING; ARTICLE; BINDING SITE; COMPLEX FORMATION; CONTROLLED STUDY; HUMAN; MOLECULAR DOCKING; MOLECULAR INTERACTION; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; RECEPTOR BINDING; SIGNAL TRANSDUCTION; VALIDATION PROCESS; CHEMICAL STRUCTURE; CHEMISTRY; METABOLISM;

BETA 2-GLYCOPROTEIN I; BINDING SITES; LIGANDS; MODELS, MOLECULAR; MULTIPROTEIN COMPLEXES; PHOSPHOLIPIDS; RECEPTORS, LIPOPROTEIN;

EID: 77649092080     PISSN: 09692126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.str.2009.12.013     Document Type: Article

References (59)

1. Andersen O.M., Benhayon D., Curran T., and Willnow T.E. Differential binding of ligands to the apolipoprotein E receptor 2. Biochemistry 42 (2003) 9355-9364
2. Beglova N., North C.L., and Blacklow S.C. Backbone dynamics of a module pair from the ligand-binding domain of the LDL receptor. Biochemistry 40 (2001) 2808-2815
3. Beglov D., Lee C.J., De Biasio A., Kozakov D., Brenke R., Vajda S., and Beglova N. Structural insights into recognition of beta2-glycoprotein I by the lipoprotein receptors. Proteins 77 (2009) 940-949
4. Blacklow S.C. Versatility in ligand recognition by LDL receptor family proteins: advances and frontiers. Curr. Opin. Struct. Biol. 17 (2007) 419-426
5. Bouma B., de Groot P.G., van den Elsen J.M., Ravelli R.B., Schouten A., Simmelink M.J., Derksen R.H., Kroon J., and Gros P. Adhesion mechanism of human beta(2)-glycoprotein I to phospholipids based on its crystal structure. EMBO J. 18 (1999) 5166-5174
6. Clayton D., Brereton I.M., Kroon P.A., and Smith R. Three-dimensional NMR structure of the sixth ligand-binding module of the human LDL receptor: comparison of two adjacent modules with different ligand binding specificities. FEBS Lett. 479 (2000) 118-122
7. Cockrell E., Espinola R.G., and McCrae K.R. Annexin A2: biology and relevance to the antiphospholipid syndrome. Lupus 17 (2008) 943-951
8. Cugno M., Borghi M.O., Lonati L.M., Ghiadoni L., Gerosa M., Grossi C., De Angelis V., Magnaghi G., Tincani A., Mari D., et al. Patients with antiphospholipid syndrome display endothelial perturbation. J. Autoimmun. (2009) 10.1016/j.jaut.2009.07.004 Published online August 3, 2009
9. Dominguez C., Boelens R., and Bonvin A.M. HADDOCK: a protein-protein docking approach based on biochemical or biophysical information. J. Am. Chem. Soc. 125 (2003) 1731-1737
10. Fischetti F., Durigutto P., Pellis V., Debeus A., Macor P., Bulla R., Bossi F., Ziller F., Sblattero D., Meroni P., and Tedesco F. Thrombus formation induced by antibodies to beta2-glycoprotein I is complement dependent and requires a priming factor. Blood 106 (2005) 2340-2346
11. Fisher C., Abdul-Aziz D., and Blacklow S.C. A two-module region of the low-density lipoprotein receptor sufficient for formation of complexes with apolipoprotein E ligands. Biochemistry 43 (2004) 1037-1044
12. Fisher C., Beglova N., and Blacklow S.C. Structure of an LDLR-RAP complex reveals a general mode for ligand recognition by lipoprotein receptors. Mol. Cell 22 (2006) 277-283
13. Giannakopoulos B., Passam F., Ioannou Y., and Krilis S.A. How we diagnose the antiphospholipid syndrome. Blood 113 (2009) 985-994
14. Hagihara Y., Goto Y., Kato H., and Yoshimura T. Role of the N- and C-terminal domains of bovine beta 2-glycoprotein I in its interaction with cardiolipin. J. Biochem. 118 (1995) 129-136
15. Hammel M., Kriechbaum M., Gries A., Kostner G.M., Laggner P., and Prassl R. Solution structure of human and bovine beta(2)-glycoprotein I revealed by small-angle X-ray scattering. J. Mol. Biol. 321 (2002) 85-97
16. Herz J., Chen Y., Masiulis I., and Zhou L. Expanding functions of lipoprotein receptors. J. Lipid Res. 50 Suppl (2009) S287-S292
17. Hoshino M., Hagihara Y., Nishii I., Yamazaki T., Kato H., and Goto Y. Identification of the phospholipid-binding site of human beta(2)-glycoprotein I domain V by heteronuclear magnetic resonance. J. Mol. Biol. 304 (2000) 927-939
18. Hubbard S.J., and Thornton J.M. NACCES (computer program) (1993), Department of Biochemistry and Molecular Biology, University College London
19. Hunt J., and Krilis S. The fifth domain of beta 2-glycoprotein I contains a phospholipid binding site (Cys281-Cys288) and a region recognized by anticardiolipin antibodies. J. Immunol. 152 (1994) 653-659
20. Jankowski M., Vreys I., Wittevrongel C., Boon D., Vermylen J., Hoylaerts M.F., and Arnout J. Thrombogenicity of beta 2-glycoprotein I-dependent antiphospholipid antibodies in a photochemically induced thrombosis model in the hamster. Blood 101 (2003) 157-162
21. Koike T., Bohgaki M., Amengual O., and Atsumi T. Antiphospholipid antibodies: lessons from the bench. J. Autoimmun. 28 (2007) 129-133
22. Korschineck I., Ziegler S., Breuss J., Lang I., Lorenz M., Kaun C., Ambros P.F., and Binder B.R. Identification of a novel exon in apolipoprotein E receptor 2 leading to alternatively spliced mRNAs found in cells of the vascular wall but not in neuronal tissue. J. Biol. Chem. 276 (2001) 13192-13197
23. Lefebvre J. Viscosity of concentrated protein solutions. Rheologica Acta 21 (1982) 620-625
24. Lim W., Crowther M.A., and Eikelboom J.W. Management of antiphospholipid antibody syndrome: a systematic review. JAMA 295 (2006) 1050-1057
25. Lutters B.C., Derksen R.H., Tekelenburg W.L., Lenting P.J., Arnout J., and de Groot P.G. Dimers of beta 2-glycoprotein I increase platelet deposition to collagen via interaction with phospholipids and the apolipoprotein E receptor 2′. J. Biol. Chem. 278 (2003) 33831-33838
26. Ma K., Simantov R., Zhang J.C., Silverstein R., Hajjar K.A., and McCrae K.R. High affinity binding of beta 2-glycoprotein I to human endothelial cells is mediated by annexin II. J. Biol. Chem. 275 (2000) 15541-15548
27. Maiti S.N., Balasubramanian K., Ramoth J.A., and Schroit A.J. Beta-2-glycoprotein 1-dependent macrophage uptake of apoptotic cells. Binding to lipoprotein receptor-related protein receptor family members. J. Biol. Chem. 283 (2008) 3761-3766
28. Masiulis I., Quill T.A., Burk R.F., and Herz J. Differential functions of the Apoer2 intracellular domain in selenium uptake and cell signaling. Biol. Chem. 390 (2009) 67-73
29. May P., Herz J., and Bock H.H. Molecular mechanisms of lipoprotein receptor signalling. Cell. Mol. Life Sci. 62 (2005) 2325-2338
30. Mehdi H., Naqvi A., and Kamboh M.I. A hydrophobic sequence at position 313-316 (Leu-Ala-Phe-Trp) in the fifth domain of apolipoprotein H (beta2-glycoprotein I) is crucial for cardiolipin binding. Eur. J. Biochem. 267 (2000) 1770-1776
31. Moestrup S.K., Gliemann J., and Pallesen G. Distribution of the alpha 2-macroglobulin receptor/low density lipoprotein receptor-related protein in human tissues. Cell Tissue Res. 269 (1992) 375-382
32. Murphy E.J., Joseph L., Stephens R., and Horrocks L.A. Phospholipid composition of cultured human endothelial cells. Lipids 27 (1992) 150-153
33. North C.L., and Blacklow S.C. Solution structure of the sixth LDL-A module of the LDL receptor. Biochemistry 39 (2000) 2564-2571
34. Olson S.T., Bock P.E., and Sheffer R. Quantitative evaluation of solution equilibrium binding interactions by affinity partitioning: application to specific and nonspecific protein-heparin interactions. Arch. Biochem. Biophys. 286 (1991) 533-545
35. Pennings M.T., van Lummel M., Derksen R.H., Urbanus R.T., Romijn R.A., Lenting P.J., and de Groot P.G. Interaction of beta2-glycoprotein I with members of the low density lipoprotein receptor family. J. Thromb. Haemost. 4 (2006) 1680-1690
36. Pennings M.T., Derksen R.H., Urbanus R.T., Tekelenburg W.L., Hemrika W., and de Groot P.G. Platelets express three different splice variants of ApoER2 that are all involved in signaling. J. Thromb. Haemost. 5 (2007) 1538-1544
37. Pennings M.T., Derksen R.H., van Lummel M., Adelmeijer J., VanHoorelbeke K., Urbanus R.T., Lisman T., and de Groot P.G. Platelet adhesion to dimeric beta-glycoprotein I under conditions of flow is mediated by at least two receptors: glycoprotein Ibalpha and apolipoprotein E receptor 2′. J. Thromb. Haemost. 5 (2007) 369-377
38. Pierangeli S.S., Liu S.W., Anderson G., Barker J.H., and Harris E.N. Thrombogenic properties of murine anti-cardiolipin antibodies induced by beta 2 glycoprotein 1 and human immunoglobulin G antiphospholipid antibodies. Circulation 94 (1996) 1746-1751
39. Pierangeli S.S., Vega-Ostertag M., and Harris E.N. Intracellular signaling triggered by antiphospholipid antibodies in platelets and endothelial cells: a pathway to targeted therapies. Thromb. Res. 114 (2004) 467-476
40. Pierangeli S.S., Vega-Ostertag M.E., Raschi E., Liu X., Romay-Penabad Z., De Micheli V., Galli M., Moia M., Tincani A., Borghi M.O., et al. Toll-like receptor and antiphospholipid mediated thrombosis: in vivo studies. Ann. Rheum. Dis. 66 (2007) 1327-1333
41. Pons J.-L., Malliavin T.E., and Delsuc M.A. Gifa V. 4: A complete package for NMR data set processing. J. Biomol. NMR 8 (1996) 445-452
42. Raschi E., Borghi M.O., Grossi C., Broggini V., Pierangeli S., and Meroni P.L. Toll-like receptors: another player in the pathogenesis of the anti-phospholipid syndrome. Lupus 17 (2008) 937-942
43. Romay-Penabad Z., Montiel-Manzano M.G., Shilagard T., Papalardo E., Vargas G., Deora A.B., Wang M., Jacovina A.T., Garcia-Latorre E., Reyes-Maldonado E., et al. Annexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo. Blood 114 (2009) 3074-3083
44. Schwarzenbacher R., Zeth K., Diederichs K., Gries A., Kostner G.M., Laggner P., and Prassl R. Crystal structure of human beta2-glycoprotein I: implications for phospholipid binding and the antiphospholipid syndrome. EMBO J. 18 (1999) 6228-6239
45. Sheng Y., Sali A., Herzog H., Lahnstein J., and Krilis S.A. Site-directed mutagenesis of recombinant human beta 2-glycoprotein I identifies a cluster of lysine residues that are critical for phospholipid binding and anti-cardiolipin antibody activity. J. Immunol. 157 (1996) 3744-3751
46. Sherer Y., Blank M., and Shoenfeld Y. Antiphospholipid syndrome (APS): where does it come from?. Best Pract. Res. Clin. Rheumatol. 21 (2007) 1071-1078
47. Shi T., Giannakopoulos B., Yan X., Yu P., Berndt M.C., Andrews R.K., Rivera J., Iverson G.M., Cockerill K.A., Linnik M.D., and Krilis S.A. Anti-beta2-glycoprotein I antibodies in complex with beta2-glycoprotein I can activate platelets in a dysregulated manner via glycoprotein Ib-IX-V. Arthritis Rheum. 54 (2006) 2558-2567
48. Shoenfeld Y., Meroni P.L., and Cervera R. Antiphospholipid syndrome dilemmas still to be solved: 2008 status. Ann. Rheum. Dis. 67 (2008) 438-442
49. Sorice M., Longo A., Capozzi A., Garofalo T., Misasi R., Alessandri C., Conti F., Buttari B., Rigano R., Ortona E., and Valesini G. Anti-beta2-glycoprotein I antibodies induce monocyte release of tumor necrosis factor alpha and tissue factor by signal transduction pathways involving lipid rafts. Arthritis Rheum. 56 (2007) 2687-2697
50. Stolt P.C., and Bock H.H. Modulation of lipoprotein receptor functions by intracellular adaptor proteins. Cell. Signal 18 (2006) 1560-1571
51. Strasser V., Fasching D., Hauser C., Mayer H., Bock H.H., Hiesberger T., Herz J., Weeber E.J., Sweatt J.D., Pramatarova A., et al. Receptor clustering is involved in Reelin signaling. Mol. Cell. Biol. 24 (2004) 1378-1386
52. Su A.I., Wiltshire T., Batalov S., Lapp H., Ching K.A., Block D., Zhang J., Soden R., Hayakawa M., Kreiman G., et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA 101 (2004) 6062-6067
53. Urbanus R.T., Derksen R.H., and de Groot P.G. Current insight into diagnostics and pathophysiology of the antiphospolipid syndrome. Blood Rev. 22 (2008) 93-105
54. Urbanus R.T., Pennings M.T., Derksen R.H., and de Groot P.G. Platelet activation by dimeric beta(2)-glycoprotein I requires signaling via both glycoprotein Ibalpha and Apolipoprotein E Receptor 2′. J. Thromb. Haemost. 6 (2008) 1405-1412
55. van Lummel M., Pennings M.T., Derksen R.H., Urbanus R.T., Lutters B.C., Kaldenhoven N., and de Groot P.G. The binding site in {beta}2-glycoprotein I for ApoER2′ on platelets is located in domain V. J. Biol. Chem. 280 (2005) 36729-36736
56. Willems G.M., Janssen M.P., Pelsers M.M., Comfurius P., Galli M., Zwaal R.F., and Bevers E.M. Role of divalency in the high-affinity binding of anticardiolipin antibody-beta 2-glycoprotein I complexes to lipid membranes. Biochemistry 35 (1996) 13833-13842
57. Yang X.V., Banerjee Y., Fernandez J.A., Deguchi H., Xu X., Mosnier L.O., Urbanus R.T., de Groot P.G., White-Adams T.C., McCarty O.J., and Griffin J.H. Activated protein C ligation of ApoER2 (LRP8) causes Dab1-dependent signaling in U937 cells. Proc. Natl. Acad. Sci. USA 106 (2009) 274-279
58. Zhang J., and McCrae K.R. Annexin A2 mediates endothelial cell activation by antiphospholipid/anti-beta2 glycoprotein I antibodies. Blood 105 (2005) 1964-1969
59. Zwaal R.F., and Schroit A.J. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood 89 (1997) 1121-1132